Small Biotechs often have a reputation for over-promising, exaggerating results and pumping the SP with unnecessary announcements.
Not MSB.
If anything their conservative approach attracts criticism for under-promoting their potential and achievements.
So when MSB releases a statement as they did this morning - it carries more weight than most.
It's still a long-shot imo - but it's a legitimate shot.
-
- There are more pages in this discussion • 155 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.71 |
Change
0.035(2.10%) |
Mkt cap ! $2.191B | |||
| Open | High | Low | Value | Volume |
| $1.67 | $1.74 | $1.67 | $3.583M | 2.091M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 30087 | $1.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.71 | 22302 | 20 |
View Market Depth
| Last trade - 13.08pm 15/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |